BioCryst Pharmaceuticals
BCRX
BCRX
100 hedge funds and large institutions have $147M invested in BioCryst Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 31 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
8% less funds holding
Funds holding: 109 → 100 (-9)
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
Holders
100
Holding in Top 10
3
Calls
$262K
Puts
$62K
Top Buyers
| 1 | +$4.83M | |
| 2 | +$2.93M | |
| 3 | +$1.26M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$804K |
| 5 |
RI
RTW Investments
New York
|
+$747K |
Top Sellers
| 1 | -$4.69M | |
| 2 | -$3.52M | |
| 3 | -$3.06M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.32M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.76M |